Close Menu

NEW YORK (GenomeWeb) – NantHealth reported after the close of the market on Wednesday that its revenues grew 25 percent year over year, but still fell short of the analysts' average estimate.

For the three months ended Dec. 31, 2017, the company posted $22.3 million in revenues, up from $17.8 million in Q4 2016, but short of the consensus Wall Street estimate of $23.3 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.